SCHEMBL285044

SCHEMBL285044

CC[C](C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18335388 0.74
SCHEMBL4267595 0.73
Butanone SCHEMBL374977 0.72
Pyruvate SCHEMBL3513977 0.71 FFAR3 (0.71)
SCHEMBL35750 0.71
SCHEMBL3280677 0.71
Propionic Acid SCHEMBL2500005 0.69
Propionic Acid SCHEMBL10444649 0.69
Butanone SCHEMBL21435671 0.69 ALDH1A1 (0.83)
Propionic Acid SCHEMBL8467208 0.69 FFAR3 (0.83)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 666 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116709916-A [ (1-phenyl-5-heteroaryl-1H-pyrazol-3-yl) oxy ] acetic acid derivatives as safeners for protecting useful plants and crop plants 拜耳公司 2023-09-05 CN claimed
CN-114886153-A Water capsule for cigarettes and preparation method and application thereof 江苏中烟工业有限责任公司 2022-08-12 CN claimed
WO-2021252379-A1 NOVEL FIRE FIGHTING FOAM SYSTEMS AND METHODS FOR MAKING AND USING SAME ENVIROCOOL LP LLC (US) 2021-12-16 WO claimed
EP-3777836-A1 OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES ALLERGAN, INC. (US) 2021-02-17 EP claimed
US-10870795-B2 Rheology modifier HALLIBURTON ENERGY SERVICES, INC. (US) 2020-12-22 US claimed
EP-2952178-B1 OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES ALLERGAN INC (US) 2020-09-02 EP claimed
US-20200062753-A1 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection HOFFMANN-LA ROCHE INC. (US) 2020-02-27 US claimed
US-10428069-B2 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection HOFFMANN-LA ROCHE INC. (US) 2019-10-01 US claimed
US-20190002757-A1 RHEOLOGY MODIFIER HALLIBURTON ENERGY SERVICES, INC. 2019-01-03 US claimed
EP-3114128-B1 NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2019-01-02 EP claimed
US-20060182806-A1 Extended-release propranolol composition GUO MINTONG 2006-08-17 US claimed
EP-1680088-A1 ANTIBIOTIC COMPOSITIONS Sandoz AG (CH) 2006-07-19 EP claimed
WO-2005060941-A1 EXTENDED RELEASE ANTIBIOTIC COMPOSITION SANDOZ AG (CH) 2005-07-07 WO claimed
US-20050136107-A1 Extended release antibiotic composition SANDOZ, INC. 2005-06-23 US claimed
WO-2005039536-A1 ANTIBIOTIC COMPOSITIONS SANDOZ AG (CH) 2005-05-06 WO claimed
US-20050084540-A1 Oral micropellets containing an antibiotic having an inner coating of a cellulose polymer (not enteric)and an outer coating of an enteric coating polymer; particle size of 100 to 650 mu m.; lack of bitter taste; fast dissolution; increased antibiotic bioavailability compared pellets having a matrix SANDOZ INC. 2005-04-21 US claimed
US-20050084541-A1 Antibiotic compositions SANDOZ, AG (CH) 2005-04-21 US claimed
EP-0526170-B1 Dyestuff for heat-sensitive transfer record and transfer sheet containing same MITSUI TOATSU CHEMICALS (JP) 1997-10-08 EP claimed
US-5567470-A COMPRISING A BENZO-2,1-ISOTHIAZOLE-AZO-PHENYL-TERTAMINES DYE; SOLVENT SOLUBILITY, LIGHT RESISTANCE, STORAGE STABILITY MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1996-10-22 US claimed
EP-0534587-B1 Sublimation transfer recording system MITSUI TOATSU CHEMICALS (JP) 1996-04-17 EP claimed